Mandate

Vinge advises SAF-HOLLAND on its takeover bid for Haldex

July 18, 2016

SAF-HOLLAND S.A. (Frankfurt Stock Exchange), through a wholly-owned subsidiary, has announced an all-cash offer to the shareholders of Haldex AB (publ) (Nasdaq Stockholm). The total offer value for all outstanding shares in Haldex amounts to SEK 4,165 million.
 
Vinge advises SAF-HOLLAND. The Vinge team is headed by capital markets and public M&A partner Erik Sjöman and includes Anders Strid, Jo-Anna Nordström, Ludvig Frithiof and Astrid Karlsson, and Henrik Ossborn and Fredrik Christiansson (financing).

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026